| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/01.CCM.0000281637.08984.6E |
| P698 | PubMed publication ID | 17855815 |
| P2093 | author name string | Gordon Jacobsen | |
| Emanuel P Rivers | |||
| Kant Shah | |||
| Manisha Loomba | |||
| James A Kruse | |||
| Ed W Childs | |||
| Ronny Otero | |||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sepsis | Q183134 |
| biomarker | Q864574 | ||
| septic shock | Q1765564 | ||
| P304 | page(s) | 2016-2024 | |
| P577 | publication date | 2007-09-01 | |
| P1433 | published in | Critical Care Medicine | Q5186605 |
| P1476 | title | The influence of early hemodynamic optimization on biomarker patterns of severe sepsis and septic shock | |
| P478 | volume | 35 |
| Q93487496 | 21st ESICM Annual Congress |
| Q35776294 | A randomized controlled trial on the effects of goal-directed therapy on the inflammatory response open abdominal aortic aneurysm repair |
| Q34570656 | A specialized post anaesthetic care unit improves fast-track management in cardiac surgery: a prospective randomized trial |
| Q30358335 | Association of physical examination with pulmonary artery catheter parameters in acute lung injury. |
| Q80965146 | Back to basics in septic shock |
| Q36993077 | Bench-to-bedside review: the initial hemodynamic resuscitation of the septic patient according to Surviving Sepsis Campaign guidelines--does one size fit all? |
| Q36920770 | Clinical review: Goal-directed therapy-what is the evidence in surgical patients? The effect on different risk groups. |
| Q26823450 | Clinical utility of biomarkers of endothelial activation in sepsis--a systematic review |
| Q36955252 | Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression |
| Q34054994 | Complement activation in emergency department patients with severe sepsis |
| Q37360357 | Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study |
| Q43028097 | Counterpoint: should lactate clearance be substituted for central venous oxygen saturation as goals of early severe sepsis and septic shock therapy? No. |
| Q36438852 | Diagnosis and treatment of severe sepsis |
| Q30432507 | Diagnosis-dependent relationships between cytokine levels and survival in patients admitted for surgical critical care |
| Q37420063 | Early Liberal Fluid Therapy for Sepsis Patients Is Not Harmful: Hydrophobia Is Unwarranted but Drink Responsibly. |
| Q26745899 | Early goal-directed therapy in severe sepsis and septic shock: insights and comparisons to ProCESS, ProMISe, and ARISE |
| Q33721339 | Early lactate clearance is associated with biomarkers of inflammation, coagulation, apoptosis, organ dysfunction and mortality in severe sepsis and septic shock |
| Q40360588 | Early risk factors and the role of fluid administration in developing acute respiratory distress syndrome in septic patients |
| Q46927405 | Early septic shock induces loss of oxidative phosphorylation yield plasticity in liver mitochondria. |
| Q30658793 | Effects of early hemodynamic resuscitation on left ventricular performance and microcirculatory function during endotoxic shock |
| Q37228127 | Evaluation of the shock index in dogs presenting as emergencies. |
| Q55083264 | Fluid Resuscitation and Markers of Glycocalyx Degradation in Severe Sepsis. |
| Q41992511 | Fluid management in critically ill patients: the role of extravascular lung water, abdominal hypertension, capillary leak, and fluid balance. |
| Q51272788 | Fluid management in the critically ill child. |
| Q90150860 | Fluid resuscitation in sepsis: the great 30 mL per kg hoax |
| Q93078629 | HSP-Target of Therapeutic Agents in Sepsis Treatment |
| Q92048334 | Initially elevated arterial lactate as an independent predictor of poor outcomes in severe acute pancreatitis |
| Q51031371 | Integrated Compensatory Responses in a Human Model of Hemorrhage. |
| Q36889928 | Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock |
| Q37724044 | Mitochondrial function and dysfunction in sepsis. |
| Q34303687 | New approaches to sepsis: molecular diagnostics and biomarkers. |
| Q33996484 | Out-of-hospital characteristics and care of patients with severe sepsis: a cohort study |
| Q26851227 | Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock |
| Q84542919 | Perioperative mechanical circulatory support in children with critical heart disease |
| Q37105993 | Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial. |
| Q37072237 | Potential interventions in sepsis-related acute kidney injury |
| Q92180084 | Prevalence and factors associated with one-year mortality of infectious diseases among elderly emergency department patients in a middle-income country |
| Q64080339 | Prognostic accuracy of the serum lactate level, the SOFA score and the qSOFA score for mortality among adults with Sepsis |
| Q37784567 | Protein C as an early biomarker to distinguish pneumonia from sepsis |
| Q35561206 | Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated). |
| Q41973191 | Recently published papers: more about EGDT, experimental therapies and some inconvenient truths. |
| Q33940879 | Reducing the burden of acute respiratory distress syndrome: the case for early intervention and the potential role of the emergency department |
| Q40375039 | Relationship Between Alternative Resuscitation Strategies, Host Response and Injury Biomarkers, and Outcome in Septic Shock: Analysis of the Protocol-Based Care for Early Septic Shock Study |
| Q37167225 | Renal hypoxia and dysoxia after reperfusion of the ischemic kidney |
| Q42936851 | Skeletal Muscle and Lymphocyte Mitochondrial Dysfunctions in Septic Shock Trigger ICU-Acquired Weakness and Sepsis-Induced Immunoparalysis. |
| Q33891519 | Systems engineering medicine: engineering the inflammation response to infectious and traumatic challenges |
| Q35922159 | THE ENDOTHELIUM IN SEPSIS. |
| Q89395900 | The Diagnosis and Hemodynamic Monitoring of Circulatory Shock: Current and Future Trends |
| Q39156935 | The effects of hypertonic fluid administration on the gene expression of inflammatory mediators in circulating leucocytes in patients with septic shock: a preliminary study |
| Q33762821 | The evolution of an inflammatory response |
| Q34562396 | The predisposition, infection, response and organ failure (Piro) sepsis classification system: results of hospital mortality using a novel concept and methodological approach |
| Q35559493 | Why do pulse pressure variations fail to predict the response to fluids in acute respiratory distress syndrome patients ventilated with low tidal volume? |
| Q53288584 | [Adequate fluid resuscitation in septic shock with high catecholamine doses]. |
| Q80606808 | [Door-to-Action-Time] |
| Q83700441 | [Pathomechanisms of organ failure. Mitochondrial dysfunction in sepsis] |
Search more.